Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3 family member pseudogene

This target is a pseudogene that resembles protein-coding genes, specifically those in the APOBEC3 family, but has lost the capacity to code for functional protein due to disruptive mutations (such as premature stop codons or frameshifts)[2][3]. Pseudogenes, now recognized as sometimes biologically active, can be transcribed into RNA and participate in regulation by: - Generating non-coding RNAs that act as microRNA decoys, sequestering microRNAs and thus modulating the expression of their parent or related genes. - Producing small interfering RNAs (siRNAs) or other small RNAs that may negatively regulate gene expression or participate in chromatin modifications. - Potentially influencing disease risk or pathogenesis when their expression is altered, especially in cancer, through indirect effects on gene regulation[1][2][3]. This pseudogene is not a therapeutic target (it does not encode a receptor, enzyme, transporter, or other classic drug target) and is typically not the focus of drug development, though the area of pseudogene-derived non-coding RNA in disease is a subject of ongoing research[1][2][3]. Key notes regarding this entry: - This is not a functional enzyme or receptor. - As a pseudogene, it may exert regulatory effects at the RNA level, but it is not a direct target for therapeutic intervention; therefore, no drugs, biomarkers, or associated safety concerns are known. - The key scientific importance lies in the regulatory capacity of pseudogene RNAs and their impact on microRNA networks and gene expression. References: See citations [1][2][3].

Other names

APOBEC3 pseudogeneApolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3 pseudogene

Acts as a microRNA decoy and may generate non-coding RNAs that participate in post-transcriptional regulation of protein-coding genes by competing for microRNA binding; potentially produces small RNAs that may be involved in chromatin repression[1][2][3].